A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males

Clinical trial NCT00475371 · COMPLETED

Trial details

NCT number: NCT00475371
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Healthy Males

Start date: 2007-04-01
Primary completion: 2007-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.